Bioray Biotech Co., Ltd (7561.TWO)

TWD 19.35

(-1.02%)

Net Debt Summary of Bioray Biotech Co., Ltd

  • Bioray Biotech Co., Ltd's latest annual net debt in 2023 was -27.23 Million TWD , up 28.62% from previous year.
  • Bioray Biotech Co., Ltd's latest quarterly net debt in 2024 Q2 was -105.54 Million TWD , up 16.29% from previous quarter.
  • Bioray Biotech Co., Ltd reported annual net debt of -38.15 Million TWD in 2022, up 47.62% from previous year.
  • Bioray Biotech Co., Ltd reported annual net debt of -72.83 Million TWD in 2021, up 13.61% from previous year.
  • Bioray Biotech Co., Ltd reported quarterly net debt of -105.54 Million TWD for 2024 Q2, up 16.29% from previous quarter.
  • Bioray Biotech Co., Ltd reported quarterly net debt of -24.66 Million TWD for 2023 Q1, up 35.36% from previous quarter.

Annual Net Debt Chart of Bioray Biotech Co., Ltd (2023 - 2019)

Historical Annual Net Debt of Bioray Biotech Co., Ltd (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -27.23 Million TWD 28.62%
2022 -38.15 Million TWD 47.62%
2021 -72.83 Million TWD 13.61%
2020 -84.31 Million TWD 45.61%
2019 -155.02 Million TWD 0.0%

Peer Net Debt Comparison of Bioray Biotech Co., Ltd

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD 115.289%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD 185.297%
Easywell Biomedicals, Inc. 123.43 Million TWD 122.061%
TTY Biopharm Company Limited -705.97 Million TWD 96.143%
Synmosa Biopharma Corporation 1.52 Billion TWD 101.79%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 100.877%
Center Laboratories, Inc. 3.91 Billion TWD 100.695%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD 52.686%
Orient Pharma Co., Ltd. 633.6 Million TWD 104.298%
InnoPharmax Inc. -17.85 Million TWD -52.492%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 97.062%
Excelsior Biopharma Inc. -212.51 Million TWD 87.186%
DV Biomed Co., Ltd. 160.7 Million TWD 116.946%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 96.515%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 95.835%
UniPharma Co., Ltd. -68.36 Million TWD 60.168%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD 105.53%
Alar Pharmaceuticals Inc. -738.05 Million TWD 96.31%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 85.803%
Mercury Biopharmaceutical Corporation -1.94 Million TWD -1300.103%
TSH Biopharm Corporation Limited -568.74 Million TWD 95.212%